BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 15 filers reported holding BIOMX INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,602,828 | -2.2% | 4,553,489 | 0.0% | 0.03% | +13.3% |
| Q2 2023 | $1,639,256 | +70.0% | 4,553,489 | +44.0% | 0.03% | +57.9% |
| Q1 2023 | $964,254 | +83.6% | 3,161,489 | +12.4% | 0.02% | +90.0% |
| Q4 2022 | $525,278 | -45.1% | 2,813,489 | 0.0% | 0.01% | -44.4% |
| Q3 2022 | $957,000 | -53.4% | 2,813,489 | 0.0% | 0.02% | -51.4% |
| Q2 2022 | $2,054,000 | -62.2% | 2,813,489 | 0.0% | 0.04% | -58.0% |
| Q1 2022 | $5,430,000 | +20.6% | 2,813,489 | 0.0% | 0.09% | +51.7% |
| Q4 2021 | $4,502,000 | -47.7% | 2,813,489 | 0.0% | 0.06% | -38.9% |
| Q3 2021 | $8,609,000 | -31.8% | 2,813,489 | +21.6% | 0.10% | -25.8% |
| Q2 2021 | $12,632,000 | -23.3% | 2,313,489 | 0.0% | 0.13% | -16.9% |
| Q1 2021 | $16,472,000 | +11.6% | 2,313,489 | 0.0% | 0.15% | +19.4% |
| Q4 2020 | $14,760,000 | +0.6% | 2,313,489 | 0.0% | 0.13% | -29.9% |
| Q3 2020 | $14,668,000 | +14.9% | 2,313,489 | 0.0% | 0.18% | +2.2% |
| Q2 2020 | $12,770,000 | -21.1% | 2,313,489 | 0.0% | 0.18% | -33.8% |
| Q1 2020 | $16,194,000 | -27.7% | 2,313,489 | 0.0% | 0.27% | -15.0% |
| Q4 2019 | $22,406,000 | – | 2,313,489 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,133,402 | $750,958 | 0.28% |
| MMCAP International Inc. SPC | 512,502 | $180,401 | 0.05% |
| Orbimed Advisors | 4,553,489 | $1,602,828 | 0.03% |
| Walleye Capital LLC | 21,056 | $7,412 | 0.00% |
| Renaissance Technologies | 144,627 | $51 | 0.00% |
| UBS Group AG | 104 | $37 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,500 | $17,424 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 4,000 | $1,408 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |